Yossi Maimon
2012 - Protalix BioTherapeutics
In 2012, Yossi Maimon earned a total compensation of $1.4M as Vice President, Chief Financial Officer at Protalix BioTherapeutics, a 272% increase compared to previous year.
Compensation breakdown
| Bonus | $157,500 |
|---|---|
| Option Awards | $544,199 |
| Salary | $268,618 |
| Stock Awards | $361,048 |
| Other | $58,231 |
| Total | $1,389,596 |
Maimon received $544.2K in option awards, accounting for 39% of the total pay in 2012.
Maimon also received $157.5K in bonus, $268.6K in salary, $361K in stock awards and $58.2K in other compensation.
Rankings
In 2012, Yossi Maimon's compensation ranked 4,850th out of 11,487 executives tracked by ExecPay. In other words, Maimon earned more than 57.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,850 out of 11,487 | 58th |
Division Manufacturing | 1,692 out of 4,252 | 60th |
Major group Chemicals And Allied Products | 398 out of 1,200 | 67th |
Industry group Drugs | 253 out of 922 | 73rd |
Industry Biological Products, Except Diagnostic Substances | 43 out of 165 | 74th |
Source: SEC filing on October 9, 2014.
Maimon's colleagues
We found four more compensation records of executives who worked with Yossi Maimon at Protalix BioTherapeutics in 2012.
2012
David Aviezer
Protalix BioTherapeutics
Chief Executive Officer
2012
Yoseph Shaaltiel
Protalix BioTherapeutics
Executive Vice President, Research and Development
2012
Einat Almon
Protalix BioTherapeutics
Senior Vice President, Product Development
2012
Tzvi Palash
Protalix BioTherapeutics